1. Home
  2. OSS vs IPHA Comparison

OSS vs IPHA Comparison

Compare OSS & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OSS

One Stop Systems Inc.

HOLD

Current Price

$7.84

Market Cap

150.4M

Sector

Technology

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$1.85

Market Cap

174.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSS
IPHA
Founded
1998
1999
Country
United States
France
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
150.4M
174.2M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
OSS
IPHA
Price
$7.84
$1.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$8.50
$5.00
AVG Volume (30 Days)
665.1K
22.5K
Earning Date
11-05-2025
09-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$60,264,017.00
$14,839,695.00
Revenue This Year
$18.00
$22.29
Revenue Next Year
$9.93
$43.90
P/E Ratio
N/A
N/A
Revenue Growth
14.33
N/A
52 Week Low
$1.85
$1.47
52 Week High
$7.92
$3.51

Technical Indicators

Market Signals
Indicator
OSS
IPHA
Relative Strength Index (RSI) 76.57 45.17
Support Level $5.81 $1.85
Resistance Level $7.92 $1.92
Average True Range (ATR) 0.50 0.07
MACD 0.28 0.00
Stochastic Oscillator 97.87 25.58

Price Performance

Historical Comparison
OSS
IPHA

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bressner segment.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Share on Social Networks: